Slingshot members are tracking this event:
AnaptysBio's (ANAB) Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Data Released
Slingshot Insights Explained
Nov 08, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Etokimab, Atlas, Phase 2b, Atopic Dermatitis, Phase 2b Eclipse Trial